Regencell Bioscience Holdings Limited (RGC) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Discover latest Regencell Bioscience Holdings Limited (RGC) short-term stock forecast for year 2025, month by month, and long-term RGC price prediction for years 2025 to 2050. Check RGC historical stock performance, analyst ratings (Buy, Sell, or Hold), and stay updated with the latest RGC news and headlines.
1 Month Prediction
$13.65 [-76.72%]
3 Month Prediction
$12.63 [-78.46%]
6 Month Prediction
$10.90 [-81.40%]
1 Year Prediction
$4.85 [-91.72%]
3 Year Prediction
$1.00 [-98.29%]
5 Year Prediction
$1.00 [-98.29%]
About Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited is a biotechnology company that focuses on research, development, and commercialization of Traditional Chinese Medicine (TCM) for treating neurocognitive disorders, specifically Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD).
THe company was established in 2014 and headquartered in Hong Kong.
Regencell Bioscience Holdings Limited (RGC) Historical Performance
IPO Date
Regencell Bioscience Holdings Limited (NASDAQ:RGC) went public on 20 July, 2021.
Change
Since inception, RGC has risen from $9.17 to $58.63, a massive 539.37% increase since 2021.
Historical Highs and Lows
In the past 4 years, the stock reached a high of $58.63 and a low of $3.36.
52 Week Range
$3.03
$64.723
The current price $58.63 is near the 52-week high, which means that the stock is overbought.
RGC Stock Price History
Based on RGC stock's historical price data, this table shows how the stock has performed in the last 4 years. Since 2021, the RGC stock has fallen from $21.4 - $36.21 to $3.8 - $58.63, which is down -1.95%. Currently, the stock follows downward trend.
Here, we have calculated stock range of RGC, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2022 | $21.4 - $36.21 | $30.05 | 31.89 | 1 Year Change |
| 2023 | $10.5 - $28.8 | $20.05 | -12.0 | 2 Year Change |
| 2024 | $3.36 - $9.63 | $6.06 | -73.4 | 3 Year Change |
| 2025 | $3.8 - $58.63 | $22.34 | -1.95 | 4 Year Change |
RGC Price Performance
6-Month Performance
RGC stock jumped by 788.33% in the last six months.
1-Year Performance
The stock has trended upwards by 1,012.52% in the past year.
3-Year Performance
In the last 3 years, the stock has soared by 161.74%.
According to Regencell Bioscience Holdings Limited's historical data, below graph gives us the exact picture of how the RGC stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 0 year and a decline in 3 years.
2022
12.43% ↓
2023
62.35% ↓
2024
52.95% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Regencell Bioscience Holdings Limited (RGC) Financials & Stock Analysis
Market Capitalization
Regencell Bioscience Holdings Limited has a market capitalization of $762.95M, which places RGC in the small-cap category.
Fundamental Analysis
Below, we have listed 12 key indicators for Fundamental analysis for RGC stock. These indicators help you understand Regencell Bioscience Holdings Limited's financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for RGC stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $13.39 |
| SMA50 | $7.91 |
| SMA200 | $6.52 |
| RSI | 95.82 |
| Beta | -0.62 |
SMA20 < Current Price
This signals RGC stock is in short-term bullish momentum.
SMA50 < Current Price
This signals RGC stock is in mid-term bullish momentum.
SMA200 < Current Price
This signals RGC stock is in long-term bullish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for RGC stock is Bullish. Out of all indicators, 6 indicates bullish signals, 3 signals bearish trends and 0 gives neutral trends. The RGC stock forecast was last updated on 22 March, 2025.
Regencell Bioscience Holdings Limited (RGC) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to fall to $10.52 by the end of 2025, and can reach around $72.57 to $13.41 in 2026. And, the long-term forecast suggests that the stock may further drop to $2.72 - $-0.25 in 2028, and $-4.20 - $3.20 by 2031. So, the RGC stock shows a strong downward trend in the next several years.
Short-term RGC Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-04 | $13.65 | -76.72% |
| 2025-05 | $14.35 | -75.52% |
| 2025-06 | $12.63 | -78.46% |
| 2025-07 | $18.50 | -68.45% |
| 2025-08 | $15.55 | -73.48% |
| 2025-09 | $10.90 | -81.41% |
| 2025-10 | $14.41 | -75.42% |
| 2025-11 | $10.12 | -82.74% |
| 2025-12 | $10.52 | -82.06% |
In 2025, the RGC stock price is expected to fluctuate between $10.12 and $18.5. According to the monthly forecast, the stock could drop to $10.52 by December 2024. If compared to the RGC's current price, the stock could lose -82.06% by the end of this year.
Long-term RGC Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $72.57 | $-47.91 | $13.41 | -77.13% |
| 2027 | $-17.41 | $2.51 | $1.68 | -97.13% |
| 2028 | $2.72 | $3.12 | $-0.25 | -100.43% |
| 2029 | $-3.75 | $0.54 | $-0.54 | -100.92% |
| 2030 | $4.16 | $-0.43 | $-5.86 | -109.99% |
| 2031 | $-4.20 | $-1.09 | $3.20 | -94.54% |
| 2032 | $7.01 | $1.23 | $2.68 | -95.43% |
| 2033 | $4.22 | $0.03 | $6.37 | -89.14% |
| 2034 | $4.81 | $2.19 | $8.02 | -86.32% |
| 2035 | $-1.60 | $-4.92 | $1.70 | -97.1% |
| 2036 | $1.38 | $-0.09 | $5.83 | -90.06% |
| 2037 | $5.89 | $3.60 | $3.96 | -93.25% |
| 2038 | $2.52 | $-2.28 | $0.25 | -99.57% |
| 2039 | $2.13 | $1.15 | $7.47 | -87.26% |
| 2040 | $-0.73 | $2.44 | $-2.95 | -105.03% |
| 2041 | $1.80 | $0.16 | $-0.05 | -100.09% |
| 2042 | $0.46 | $1.95 | $4.77 | -91.86% |
| 2043 | $-4.61 | $-0.68 | $-2.39 | -104.08% |
| 2044 | $5.84 | $0.30 | $2.68 | -95.43% |
| 2045 | $0.32 | $-0.46 | $0.28 | -99.52% |
| 2046 | $0.69 | $0.02 | $-0.25 | -100.43% |
| 2047 | $0.96 | $0.00 | $1.00 | -98.29% |
| 2048 | $5.09 | $-1.00 | $4.03 | -93.13% |
| 2049 | $1.02 | $8.68 | $2.07 | -96.47% |
| 2050 | $-0.32 | $-2.08 | $-2.54 | -104.33% |
| 2051 | $2.27 | $-2.13 | $1.84 | -96.86% |
Regencell Bioscience Holdings Limited (RGC) Stock Price Prediction & Forecast 2025
At the start of 2025, the RGC stock was at $3.80. Today, it is trading at $58.63, which is 1442.89% increase from price at the beginning of the year. By the end of this year, you can expect the stock to fall to $10.52 by December 2025 with a -82.06% change.
Regencell Bioscience Holdings Limited (RGC) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the RGC stock. During this period, the RGC's price is forecasted to shift from $72.57 to $-5.86, which is -108.07% loss.
In 2026, the stock would possibly open at $72.57, descends to $-47.91 by mid-year, and wraps up at $13.41, reflecting a decrease from today's price. Further moving to 2030, the stock can kick off the year at $4.16, drop to $-0.43 by mid-year, and finish at $-5.86, which is -109.99% change from current price.
Regencell Bioscience Holdings Limited (RGC) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $-4.20 to $-2.95, which is down -94.54%
In 2031, we can expect RGC to fluctuate between $3.20 and $-4.20, a shift indicating a -94.54% loss by year-end compared to current price. And Until 2040, RGC can likely vary from $-0.73 to $-2.95. By the end of 2040, the stock could record a -105.03% fall from today's stock price.
Regencell Bioscience Holdings Limited (RGC) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the RGC stock can see an a downturn from $1.80 to $-2.54 in this period. In 2041, the stock can experience a low of $0.16 by mid-year, closing the year at $-0.05. This results in a -99.73% decrease from today.
Moving towards the end of 2050, RGC is projected to open the year at $-0.32. The stock may peak to $-2.08 during mid-year and finish the year at $-2.54. Compared to the stock's current price, this translates to an overall loss of -104.33% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
RGC Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| SNOA | Sonoma Pharmaceuticals, Inc. | - | $3.53 | 55.51% ▲ | $92.22 ▲ |
| GTBIF | Green Thumb Industries Inc. | - | $6.75 | -2.88% ▼ | $194.39 ▲ |
| TLRY | Tilray Brands, Inc. | - | $0.65 | -12.08% ▼ | $293.75 ▲ |
Last updated Mar 22 at 8:16 PM
RGC : Buy, Sell Or Hold?
Analyst Ratings
No analyst ratings available for this stock.
Expert Analysis
According to RGC short-term and long-term forecast, Regencell Bioscience Holdings Limited shares are projected to go down by 104.33%, and reach a value of $-2.54 per share by 2050.
As per technical analysis, indicators show a Bullish sentiment, while Fear & Greed Index stands at 50.0, which signals Fear. Also, RGC has recorded 15/30 green days, which reflects a 65.21739130434783% positivity rate with a price volatility of 0.46%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that RGC stock is undervalued. So, Based on RGC prediction and analysis, it may be the best time to hold RGC stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "RGC” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.